Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 154,689,322
  • Shares Outstanding, K 1,550,304
  • Annual Sales, $ 45,811 M
  • Annual Income, $ 5,955 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 3.86
  • Price/Cash Flow 17.44
  • Price/Book 4.81
  • Price/Earnings ttm 30.46
  • Earnings Per Share ttm 4.12
  • Most Recent Earnings $1.24 on 07/25/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield 2.89 (2.34%)
  • Most Recent Dividend 0.776 on 08/08/24
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9,670.000 +3.20%
on 11/07/24
12,204.000 -18.23%
on 10/21/24
-1,924.307 (-16.17%)
since 10/18/24
3-Month
9,670.000 +3.20%
on 11/07/24
13,388.000 -25.46%
on 09/03/24
-3,070.998 (-23.53%)
since 08/19/24
52-Week
9,461.000 +5.48%
on 02/12/24
13,388.000 -25.46%
on 09/03/24
-281.000 (-2.74%)
since 11/17/23

Most Recent Stories

More News
Stock Index Futures Inch Higher as Investors Mull Size of Fed Rate Cut, U.S. Economic Data on Tap

September S&P 500 E-Mini futures (ESU24) are up +0.23%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.08% this morning, while Treasury yields slumped after fresh U.S. economic data left investors...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
WBD : 9.47 (+2.71%)
KR : 58.06 (+0.07%)
ROKU : 74.03 (+7.49%)
MRNA : 39.51 (+7.22%)
MU : 97.51 (+1.21%)
AZN.LN : 9,973.594 (+0.59%)
ADBE : 499.51 (-0.77%)
RH : 318.86 (+1.00%)
ARM : 128.66 (-0.05%)
BA : 143.87 (+2.63%)
Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations

The Biden administration says Medicare recipients will save about $1.5 billion dollars on medications to for diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with...

BMY : 56.80 (+1.03%)
AZN.LN : 9,973.594 (+0.59%)
RSG : 209.08 (+0.50%)
RILY : 4.60 (-2.54%)
Astrazeneca: Q2 Earnings Snapshot

Astrazeneca: Q2 Earnings Snapshot

AZN.LN : 9,973.594 (+0.59%)
Stock Index Futures Mixed Ahead of More Fed Speak, Nvidia Earnings Awaited

June S&P 500 E-Mini futures (ESM24) are up +0.03%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.08% this morning as investors awaited further comments from Federal Reserve officials while also...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
NCLH : 26.10 (-1.21%)
MU : 97.51 (+1.21%)
NVDA : 140.15 (-1.29%)
JPM : 245.03 (-0.11%)
LOW : 271.77 (+0.88%)
AZO : 3,166.93 (+1.91%)
TOL : 152.41 (-0.17%)
M : 15.26 (-1.48%)
URBN : 38.40 (+0.47%)
SFSN.Z.EB : 123.200 (-0.81%)
AstraZeneca pulls its COVID-19 vaccine from the European market

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled

$SPX : 5,893.62 (+0.39%)
$DOWI : 43,389.60 (-0.13%)
$IUXX : 20,539.19 (+0.71%)
AZN.LN : 9,973.594 (+0.59%)
AZN : 63.39 (+0.25%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 9,973.594 (+0.59%)
AZN : 63.39 (+0.25%)
GSK.LN : 1,297.500 (-0.95%)
GSK : 33.69 (+1.02%)
International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall, Tuesday, 3/19/2024

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall

SMCI : 21.54 (+15.93%)
IP : 57.70 (+0.21%)
CRNX : 53.70 (-1.86%)
AZN.LN : 9,973.594 (+0.59%)
AZN : 63.39 (+0.25%)
FUSN : 21.55 (+0.14%)
FCX : 43.55 (+1.99%)
UL : 57.90 (+0.87%)
ULVR.LN : 4,544.500 (-0.23%)
Stocks Slip Before the Open as Investors Await Earnings Reports, Disney Climbs on Strong Results

March S&P 500 E-Mini futures (ESH24) are down -0.18%, and March Nasdaq 100 E-Mini futures (NQH24) are down -0.16% this morning as market participants braced for the next round of quarterly results.

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
DIS : 113.54 (-1.34%)
EMR : 129.16 (+1.88%)
CMG : 58.81 (+0.31%)
F : 11.21 (+1.82%)
VFC : 19.59 (-2.83%)
SNAP : 10.55 (-0.47%)
COP : 113.76 (+1.28%)
PM : 131.72 (+2.43%)
DUK : 113.54 (+1.22%)
EXPE : 180.40 (-0.52%)
Stock market today: Asian shares are mixed ahead of the Fed's decision on interest rates

Asian shares are mixed after Wall Street rose to its highest level since early 2022, slightly below its record high, after a report showed inflation in the United States is behaving pretty much as expected...

M : 15.26 (-1.48%)
GOOGL : 175.30 (+1.63%)
ADBE : 499.51 (-0.77%)
HAS : 61.69 (-0.84%)
AZN.LN : 9,973.594 (+0.59%)
AZN : 63.39 (+0.25%)
$SPX : 5,893.62 (+0.39%)
$DOWI : 43,389.60 (-0.13%)
$IUXX : 20,539.19 (+0.71%)
ORCL : 185.73 (+1.08%)
NVDA : 140.15 (-1.29%)
FB : 196.64 (+0.51%)
Oracle, Hasbro fall; Icosavax, Perion Network rise, Tuesday, 12/12/2023

Stocks that traded heavily or had substantial price changes on Tuesday: Oracle, Hasbro fall; Icosavax, Perion Network rise

CHH : 145.98 (-0.17%)
PFE : 24.86 (+0.24%)
AZN.LN : 9,973.594 (+0.59%)
AZN : 63.39 (+0.25%)
ORCL : 185.73 (+1.08%)
HAS : 61.69 (-0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 10,059.667
2nd Resistance Point 10,002.333
1st Resistance Point 9,958.667
Last Price 9,973.594
1st Support Level 9,857.667
2nd Support Level 9,800.333
3rd Support Level 9,756.667

See More

52-Week High 13,388.000
Fibonacci 61.8% 11,887.886
Fibonacci 50% 11,424.500
Fibonacci 38.2% 10,961.113
Last Price 9,973.594
52-Week Low 9,461.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar